Allworth Financial’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $51K | Buy |
4,545
+4,501
| +10,230% | +$50.5K | ﹤0.01% | 1922 |
|
2025
Q1 | $255 | Sell |
44
-183
| -81% | -$1.06K | ﹤0.01% | 3819 |
|
2024
Q4 | $1.77K | Sell |
227
-170
| -43% | -$1.33K | ﹤0.01% | 3189 |
|
2024
Q3 | $1.92K | Buy |
397
+227
| +134% | +$1.1K | ﹤0.01% | 2982 |
|
2024
Q2 | $1.17K | Buy |
+170
| New | +$1.17K | ﹤0.01% | 3114 |
|
2023
Q4 | – | Sell |
-1
| Closed | -$14 | – | 3630 |
|
2023
Q3 | $14 | Sell |
1
-97
| -99% | -$1.36K | ﹤0.01% | 3396 |
|
2023
Q2 | $1.84K | Buy |
98
+11
| +13% | +$206 | ﹤0.01% | 2520 |
|
2023
Q1 | $1.26K | Buy |
+87
| New | +$1.26K | ﹤0.01% | 2588 |
|